URB597 Size:2mg solid InChiKey: RYSMHWILUNYBFW-GRIPGOBMSA-N

InChiKey: RYSMHWILUNYBFW-GRIPGOBMSA-N

the Ki values are 91 nM

LY2157199 treatment stimulates hematopoiesis from primary MDS bone marrow specimens

is orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway

URB597 Size:2mg solid InChiKey: RYSMHWILUNYBFW-GRIPGOBMSA-NURB597, also known as KDS 4103, is a relatively selective inhibitor of the enzyme fatty acid amide hydrolase (FAAH). FAAH is the primary degradatory enzyme for the endocannabinoid anandamide and, as such, inhibition of FAAH leads to an accumulation of anandamide in the CNS and periphery where it activates cannabinoid receptors. In pre clinical laboratory tests researchers found URB597 increased the production of endocannabinoids resulting in